Vaxcyte Inc.
PCVX | NASDAQ
$58.92
+$0.79 (+1.36%)
At close: Sep 21, 2026, 4:00 PM ET
$59.40
+$0.48 (+0.81%)
Pre-market:
Sep 22, 2026, 8:19 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 5.85M | -4.99M | n/a | 4.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -5.85M | 4.99M | n/a | -4.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -302.78M | -345.85M | -274.28M | -242.38M | -226.22M | -180.79M | -162.17M | -139.92M | -152.98M | -114.47M | -196.68M | -113.03M | -87.15M | -71.19M | -86.57M | -58.58M | -47.89M | -39.22M | -29.85M | -26.95M | -23.73M | -23.14M |
Interest Income | 25.76M | 26.61M | 26.45M | 29.26M | 31.07M | 32.94M | 36.46M | 28.06M | 23.81M | 21.67M | 17.57M | 18.5M | 16.45M | 10.39M | 6.63M | 1.19M | 399K | 134K | 99K | 90K | 93K | 61K |
Pretax Income | -284.3M | -320.62M | -246.51M | -212.83M | -166.57M | -140.72M | -137.08M | -103.12M | -128.7M | -95.02M | -180.8M | -92.66M | -68.34M | -60.46M | -78.05M | -57.92M | -48.53M | -38.99M | -28.56M | -26.62M | -23.68M | -21.22M |
Net Income | -284.3M | -320.62M | -246.51M | -212.83M | -166.57M | -140.72M | -137.08M | -103.12M | -128.7M | -95.02M | -180.8M | -92.66M | -68.34M | -60.46M | -78.05M | -57.92M | -48.53M | -38.99M | -28.56M | -26.62M | -23.68M | -21.22M |
Selling & General & Admin | 34.93M | 33.07M | 32.22M | 32.45M | 32.04M | 32.66M | 28.56M | 22.99M | 21.47M | 19.89M | 17.53M | 15.61M | 14.46M | 13.11M | 11.95M | 10.9M | 9.42M | 7.54M | 6.77M | 6.52M | 6.08M | 5.89M |
Research & Development | 267.85M | 312.78M | 242.06M | 209.93M | 194.18M | 148.13M | 133.61M | 116.94M | 131.51M | 94.59M | 104.15M | 97.42M | 72.69M | 58.08M | 51.63M | 47.68M | 38.47M | 31.68M | 23.07M | 20.43M | 17.65M | 17.26M |
Other Expenses | n/a | -5.85M | 4.99M | n/a | -4.99M | n/a | n/a | n/a | n/a | n/a | 75M | n/a | n/a | n/a | 23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 302.78M | 340M | 279.27M | 242.38M | 221.23M | 180.79M | 162.17M | 139.92M | 152.98M | 114.47M | 196.68M | 113.03M | 87.15M | 71.19M | 86.57M | 58.58M | 47.89M | 39.22M | 29.85M | 26.95M | 23.73M | 23.14M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | n/a | n/a | n/a | 7K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 302.78M | 345.85M | 274.28M | 242.38M | 226.22M | 180.79M | 162.17M | 139.92M | 152.98M | 114.47M | 196.68M | 113.03M | 87.15M | 71.19M | 86.57M | 58.58M | 47.89M | 39.22M | 29.85M | 26.95M | 23.73M | 23.14M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 144.49M | 139.51M | 136.09M | 136.2M | 136.03M | 135.69M | 122.85M | 123.69M | 117.26M | 111.69M | 104.42M | 101.67M | 98.06M | 86.21M | 75.54M | 61.99M | 60.82M | 57.55M | 54.73M | 52.19M | 51.51M | 51.17M |
Shares Outstanding (Diluted) | 144.49M | 139.51M | 136.09M | 136.2M | 136.03M | 135.69M | 122.85M | 123.69M | 117.26M | 111.69M | 104.42M | 101.67M | 98.06M | 86.21M | 75.54M | 61.99M | 60.82M | 57.55M | 54.73M | 52.19M | 51.51M | 51.17M |
EPS (Basic) | -1.97 | -2.30 | -1.81 | -1.56 | -1.22 | -1.04 | -1.12 | -0.83 | -1.10 | -0.85 | -1.73 | -0.91 | -0.70 | -0.70 | -1.03 | -0.93 | -0.80 | -0.68 | -0.52 | -0.51 | -0.46 | -0.41 |
EPS (Diluted) | -1.97 | -2.30 | -1.81 | -1.56 | -1.22 | -1.04 | -1.12 | -0.83 | -1.10 | -0.85 | -1.73 | -0.91 | -0.70 | -0.70 | -1.03 | -0.93 | -0.80 | -0.68 | -0.52 | -0.51 | -0.46 | -0.41 |
EBITDA | -292.5M | -314.77M | -234.57M | -209.77M | -161.58M | -135.84M | -52.58M | -135.14M | -125.23M | -91.93M | -177.85M | -108.91M | -82.28M | -68.2M | -75.75M | -55.56M | -46.36M | -36.69M | -27.36M | -25.76M | -22.8M | -22.62M |
EBIT | -295.5M | -320.62M | -246.51M | -212.83M | -166.57M | -140.72M | -57.36M | -139.63M | -128.7M | -95.02M | -180.8M | -111.39M | -84.68M | -70.54M | -78.05M | -57.92M | -48.53M | -39.06M | -28.56M | -26.62M | -23.67M | -23.14M |
Depreciation & Amortization | 3M | 5.85M | 11.93M | 3.06M | 4.99M | 4.87M | 4.79M | 4.49M | 3.48M | 3.09M | 2.95M | 2.48M | 2.4M | 2.34M | 2.3M | 2.35M | 2.17M | 2.37M | 1.21M | 856K | 868K | 527K |
Add to Watchlist
Select watchlists to add or remove PCVX